A fecal-based test for the detection of advanced adenoma and colorectal cancer: A case-control and screening cohort study
BMC Medicine Oct 29, 2021
Cao LJ, Peng XL, Xue WQ, et al. - Researchers aimed at determining a fecal-based, noninvasive, and accurate method for detection of colorectal cancer (CRC) and advanced adenoma (AA).
From the candidate biomarkers for CRC and AA detection, researchers identified the methylated DNA marker ITGA4 and bacterial markers Fusobacterium nucleatum (Fn) and Pepetostreptococcusanaerobius (Pa) via analyzing tissue (n = 96) and fecal samples (n = 88) and testing in an independent group of fecal samples (n = 294).
Using the selected markers and fecal immunochemical test (FIT), they generated a prediction score (pd-score) for distinguishing AA and CRC from healthy individuals.
Findings support the utility of this noninvasive and well-validated score for AA and CRC detection.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries